RNAi

The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.

Researchers from the Broad Institute and Novartis used RNA interference to generate catalogs of genes that cancer cells rely on to grow and survive.

Researchers described the development and testing of layered double hydroxide nanosheets as carriers for RNAi molecules in agriculture.

By comparing Cryptococcus genomes, Duke researchers found that C. deuterogattii lacks certain RNAi pathway genes, possibly contributing to its high virulence.